An AIIMS-led study has found that a government-funded influenza vaccination programme for adults aged 60 years and above would be cost-effective, with prioritising older adults with chronic illnesses such as diabetes, heart disease and chronic lung disease emerging as the most cost-effective strategy.
News
First India study backs govt-funded annual flu vaccine for seniors
June 28, 2026An AIIMS-led study has found that a government-funded influenza vaccination programme for adults aged 60 years and above would be cost-effective, with prioritising older adults with chronic illnesses such as diabetes, heart disease and chronic lung disease emerging as the most cost-effective strategy.